Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proctocolectomy, Restorative | 13 | 2016 | 115 | 1.240 |
Why?
|
| Crohn Disease | 16 | 2015 | 806 | 1.200 |
Why?
|
| Colitis, Ulcerative | 15 | 2017 | 801 | 0.980 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2015 | 249 | 0.860 |
Why?
|
| Aspirin | 3 | 2015 | 169 | 0.830 |
Why?
|
| Intestinal Mucosa | 7 | 2015 | 825 | 0.740 |
Why?
|
| Colonic Pouches | 8 | 2016 | 97 | 0.690 |
Why?
|
| Postoperative Complications | 20 | 2014 | 2591 | 0.670 |
Why?
|
| Laparoscopy | 10 | 2014 | 784 | 0.660 |
Why?
|
| Colectomy | 9 | 2014 | 192 | 0.560 |
Why?
|
| Intestinal Obstruction | 4 | 2015 | 94 | 0.550 |
Why?
|
| Mannitol | 3 | 2015 | 51 | 0.510 |
Why?
|
| Lactulose | 3 | 2015 | 22 | 0.500 |
Why?
|
| Digestive System Surgical Procedures | 6 | 2013 | 134 | 0.500 |
Why?
|
| Intestinal Absorption | 2 | 2014 | 126 | 0.500 |
Why?
|
| Constriction, Pathologic | 5 | 2015 | 220 | 0.490 |
Why?
|
| Carbohydrates | 1 | 2014 | 49 | 0.420 |
Why?
|
| Rectum | 4 | 2014 | 151 | 0.400 |
Why?
|
| Rectal Neoplasms | 3 | 2014 | 134 | 0.340 |
Why?
|
| Perineum | 3 | 2014 | 37 | 0.320 |
Why?
|
| Anastomosis, Surgical | 7 | 2011 | 283 | 0.310 |
Why?
|
| Inflammatory Bowel Diseases | 5 | 2014 | 647 | 0.290 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 630 | 0.290 |
Why?
|
| Follow-Up Studies | 15 | 2017 | 3927 | 0.280 |
Why?
|
| Smoking | 1 | 2012 | 653 | 0.280 |
Why?
|
| Prospective Studies | 18 | 2016 | 4671 | 0.280 |
Why?
|
| Adult | 33 | 2017 | 28718 | 0.270 |
Why?
|
| Anal Canal | 4 | 2011 | 92 | 0.260 |
Why?
|
| Permeability | 4 | 2015 | 144 | 0.240 |
Why?
|
| Preoperative Care | 2 | 2014 | 418 | 0.220 |
Why?
|
| Neoplasm, Residual | 1 | 2005 | 194 | 0.210 |
Why?
|
| Female | 36 | 2017 | 50063 | 0.210 |
Why?
|
| Pouchitis | 2 | 2008 | 57 | 0.210 |
Why?
|
| Anus Diseases | 2 | 2015 | 16 | 0.200 |
Why?
|
| Urine | 2 | 2014 | 96 | 0.190 |
Why?
|
| Ileal Diseases | 2 | 2007 | 25 | 0.190 |
Why?
|
| Adenomatous Polyposis Coli | 2 | 2000 | 45 | 0.190 |
Why?
|
| Male | 33 | 2017 | 45870 | 0.190 |
Why?
|
| Humans | 42 | 2017 | 96127 | 0.180 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 1773 | 0.180 |
Why?
|
| Middle Aged | 23 | 2017 | 28363 | 0.170 |
Why?
|
| Adenocarcinoma | 2 | 2005 | 1215 | 0.170 |
Why?
|
| Reoperation | 8 | 2013 | 707 | 0.170 |
Why?
|
| Colorectal Neoplasms | 4 | 2017 | 1069 | 0.160 |
Why?
|
| Treatment Outcome | 15 | 2014 | 9173 | 0.160 |
Why?
|
| Ileostomy | 3 | 2011 | 29 | 0.150 |
Why?
|
| Surgical Flaps | 1 | 2001 | 259 | 0.150 |
Why?
|
| Surgical Stapling | 3 | 2008 | 17 | 0.140 |
Why?
|
| Defecation | 3 | 2008 | 26 | 0.140 |
Why?
|
| Time Factors | 7 | 2013 | 5585 | 0.140 |
Why?
|
| Venous Thrombosis | 2 | 2014 | 257 | 0.140 |
Why?
|
| Intraoperative Complications | 2 | 1997 | 197 | 0.140 |
Why?
|
| Thrombospondins | 1 | 2017 | 15 | 0.130 |
Why?
|
| Caveolin 1 | 1 | 2017 | 25 | 0.130 |
Why?
|
| Recurrence | 6 | 2010 | 1218 | 0.130 |
Why?
|
| Collagen Type I | 1 | 2017 | 74 | 0.130 |
Why?
|
| Adolescent | 11 | 2016 | 9896 | 0.130 |
Why?
|
| Aged | 14 | 2016 | 20964 | 0.130 |
Why?
|
| Quality of Life | 6 | 2014 | 1816 | 0.130 |
Why?
|
| Focal Adhesions | 1 | 2017 | 66 | 0.130 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2015 | 311 | 0.120 |
Why?
|
| Suture Techniques | 4 | 2008 | 143 | 0.120 |
Why?
|
| Ostomy | 1 | 2015 | 15 | 0.120 |
Why?
|
| Intestinal Fistula | 1 | 2015 | 31 | 0.120 |
Why?
|
| Ascorbic Acid | 1 | 2015 | 40 | 0.110 |
Why?
|
| Rhamnose | 1 | 2014 | 4 | 0.110 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2014 | 20 | 0.110 |
Why?
|
| Intestine, Small | 5 | 2015 | 310 | 0.110 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 197 | 0.110 |
Why?
|
| Clostridium Infections | 1 | 2016 | 128 | 0.100 |
Why?
|
| Portal Vein | 1 | 2014 | 122 | 0.100 |
Why?
|
| Hernia, Femoral | 1 | 1992 | 2 | 0.100 |
Why?
|
| Colitis | 2 | 2007 | 262 | 0.100 |
Why?
|
| Ascites | 1 | 1992 | 58 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2017 | 592 | 0.090 |
Why?
|
| Risk Factors | 6 | 2014 | 5960 | 0.090 |
Why?
|
| Hernia, Inguinal | 1 | 1992 | 75 | 0.090 |
Why?
|
| Young Adult | 5 | 2016 | 7025 | 0.090 |
Why?
|
| Retrospective Studies | 10 | 2016 | 10286 | 0.090 |
Why?
|
| Intestines | 2 | 2011 | 431 | 0.080 |
Why?
|
| Mesenteric Veins | 2 | 2014 | 36 | 0.080 |
Why?
|
| Microbiota | 1 | 2016 | 426 | 0.080 |
Why?
|
| Chi-Square Distribution | 4 | 2010 | 363 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 2040 | 0.080 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 247 | 0.080 |
Why?
|
| Length of Stay | 3 | 2013 | 833 | 0.070 |
Why?
|
| Robotics | 1 | 2011 | 273 | 0.070 |
Why?
|
| Abscess | 2 | 2014 | 95 | 0.070 |
Why?
|
| S-Nitrosoglutathione | 1 | 2007 | 10 | 0.070 |
Why?
|
| Enteric Nervous System | 1 | 2007 | 7 | 0.070 |
Why?
|
| Colonic Diseases | 1 | 2007 | 61 | 0.070 |
Why?
|
| Transcriptome | 1 | 2013 | 770 | 0.070 |
Why?
|
| Blood Loss, Surgical | 3 | 2013 | 133 | 0.070 |
Why?
|
| Morbidity | 1 | 2007 | 160 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 1431 | 0.060 |
Why?
|
| Astrocytes | 1 | 2007 | 151 | 0.060 |
Why?
|
| Incidence | 3 | 2014 | 1715 | 0.060 |
Why?
|
| Wound Healing | 2 | 2014 | 378 | 0.060 |
Why?
|
| Colon | 3 | 2013 | 541 | 0.060 |
Why?
|
| Analysis of Variance | 3 | 2007 | 910 | 0.060 |
Why?
|
| Prognosis | 4 | 2017 | 4033 | 0.060 |
Why?
|
| Postoperative Period | 1 | 2005 | 318 | 0.050 |
Why?
|
| Diagnostic Errors | 1 | 2005 | 159 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2005 | 590 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2000 | 7232 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 1807 | 0.050 |
Why?
|
| Surgical Wound Infection | 2 | 2014 | 237 | 0.050 |
Why?
|
| Operative Time | 2 | 2013 | 167 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2005 | 444 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2014 | 1010 | 0.040 |
Why?
|
| Intestinal Neoplasms | 1 | 2001 | 70 | 0.040 |
Why?
|
| Rectovaginal Fistula | 1 | 2000 | 7 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2004 | 1981 | 0.040 |
Why?
|
| Peristalsis | 1 | 2000 | 10 | 0.040 |
Why?
|
| Rectal Fistula | 1 | 2000 | 19 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2008 | 2480 | 0.040 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2003 | 287 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 514 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 1534 | 0.040 |
Why?
|
| Ileum | 1 | 2000 | 169 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2007 | 2860 | 0.040 |
Why?
|
| Hepatectomy | 1 | 2000 | 178 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2000 | 239 | 0.040 |
Why?
|
| Methods | 1 | 1998 | 148 | 0.040 |
Why?
|
| Duodenum | 1 | 1998 | 112 | 0.030 |
Why?
|
| Acute Disease | 1 | 1998 | 872 | 0.030 |
Why?
|
| Metronidazole | 1 | 1996 | 26 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 1996 | 25 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 1996 | 41 | 0.030 |
Why?
|
| Dehydration | 1 | 2015 | 20 | 0.030 |
Why?
|
| Intraabdominal Infections | 1 | 2015 | 10 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 1995 | 53 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 1996 | 96 | 0.030 |
Why?
|
| Ulcer | 1 | 2014 | 38 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2014 | 38 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2015 | 318 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2015 | 397 | 0.030 |
Why?
|
| Tight Junctions | 1 | 2015 | 153 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2000 | 793 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2014 | 315 | 0.030 |
Why?
|
| Conversion to Open Surgery | 1 | 2013 | 11 | 0.020 |
Why?
|
| Rectal Diseases | 1 | 2013 | 23 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2011 | 3107 | 0.020 |
Why?
|
| Infliximab | 1 | 2013 | 163 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2013 | 395 | 0.020 |
Why?
|
| Algorithms | 1 | 2000 | 2014 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2013 | 479 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 299 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 1349 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1351 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 527 | 0.020 |
Why?
|
| Chicago | 1 | 2016 | 1503 | 0.020 |
Why?
|
| Intestinal Perforation | 1 | 2011 | 39 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1995 | 589 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1791 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 1992 | 276 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 701 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2013 | 369 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2015 | 513 | 0.020 |
Why?
|
| Child | 2 | 2003 | 7626 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 741 | 0.020 |
Why?
|
| Inflammation | 1 | 1996 | 1068 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2006 | 1175 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 311 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1268 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1996 | 1469 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2013 | 413 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 1665 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 1829 | 0.020 |
Why?
|
| Fecal Incontinence | 1 | 2008 | 59 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1958 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2008 | 175 | 0.020 |
Why?
|
| Age Distribution | 1 | 2008 | 209 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 995 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 365 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 1874 | 0.020 |
Why?
|
| Zonula Occludens-2 Protein | 1 | 2007 | 11 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2007 | 27 | 0.020 |
Why?
|
| Observation | 1 | 2007 | 38 | 0.020 |
Why?
|
| Norethindrone | 1 | 2007 | 13 | 0.020 |
Why?
|
| Dextrans | 1 | 2007 | 78 | 0.020 |
Why?
|
| Occludin | 1 | 2007 | 66 | 0.020 |
Why?
|
| Italy | 1 | 2007 | 112 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2008 | 348 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2007 | 214 | 0.020 |
Why?
|
| Japan | 1 | 2007 | 313 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 3586 | 0.020 |
Why?
|
| Estradiol | 1 | 2007 | 256 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 380 | 0.010 |
Why?
|
| Epithelium | 1 | 2007 | 326 | 0.010 |
Why?
|
| Dogs | 1 | 2007 | 719 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2005 | 41 | 0.010 |
Why?
|
| Testosterone | 1 | 2007 | 277 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2007 | 798 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 983 | 0.010 |
Why?
|
| Short Bowel Syndrome | 1 | 2005 | 38 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 930 | 0.010 |
Why?
|
| Actins | 1 | 2007 | 473 | 0.010 |
Why?
|
| Biopsy | 1 | 2007 | 1220 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 1645 | 0.010 |
Why?
|
| Laparotomy | 1 | 2003 | 69 | 0.010 |
Why?
|
| Gene Expression | 1 | 2007 | 1322 | 0.010 |
Why?
|
| RNA | 1 | 2007 | 606 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 901 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 2943 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2005 | 463 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 4154 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 1276 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2003 | 935 | 0.010 |
Why?
|
| Age Factors | 1 | 2003 | 1963 | 0.010 |
Why?
|
| Survival Rate | 1 | 2000 | 1986 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2000 | 2081 | 0.010 |
Why?
|
| United States | 1 | 2007 | 7767 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 12562 | 0.010 |
Why?
|
| Animals | 1 | 2007 | 28945 | 0.000 |
Why?
|